The present invention and creation is utilized in intravenous injection, capable of enhancing the safety of injection while alleviating the injection pain for patients.
Analysis of the prospects for authorization abroad, in response to the written opinion of the international search authority;
A modification plan for claims that takes into account the applicant's inventive conception, the technical solution of the actual product, and the protection demands, considering both the completeness and rationality of protection while being capable of overcoming the issue of inventiveness;
Based on the applicant's market strategic planning, product characteristics, and the intellectual property protection environment of various countries, a tailor-made overseas country layout plan was crafted for the applicant. Eventually, the United States, Europe, South Korea, Japan, Eurasia, Mexico, Australia, Brazil, Malaysia, Vietnam, Singapore, Thailand, Saudi Arabia, India, and South Africa were chosen as target countries for patent applications. Eventually, Sunshine IP successfully aided the applicant in obtaining patent authorizations in the aforementioned 15 countries and regions.
In the European and Eurasian regions, patent validation and protection have been further obtained in countries such as Luxembourg, Greece, Switzerland, Ireland, the United Kingdom, France, Germany, Spain, Turkey, Italy, Portugal, Malta, and Russia.
